Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 5, 2005, Pages 714-718

  Nemote, Y ^a   Kuwabara, Satoshi ^a   Misawa, S ^a   Kawaguchi, N ^a   Hattori, T ^a   Takamori, M ^b   Vincent, A ^c  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kanazawa Nishi Hospital   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MUSCLE SPECIFIC TYROSINE KINASE; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PROTEIN TYROSINE KINASE; RYANODINE RECEPTOR; RYANODINE RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; ELECTROMYOGRAPHY; EXCITATION CONTRACTION COUPLING; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SEVERITY OF ILLNESS INDEX; SYNAPTIC TRANSMISSION;

EID: 17644369970     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.043125     Document Type: Article

References (23)

1. Lindstorm JM, Seybold ME, Lennon VA, et al. Antibody to acetylcholine receptor in myasthenia gravis. Neurology 1976;26:1054-9.
2. Lefvert AK, Bergstorm K, Matell G, et al. Determination of acelylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 1978;41:394-403.
3. Soliven BC, Lange DJ, Penn AS, et al. Seronegative myasthenia gravis. Neurology 1988;38:514-6.
4. Sanders DB, Andrewa PI, Howard JF Jr, et al. Seronegative myasthenia gravis. Neurology 1997;48(Suppl 5):S40-5.
5. Stȧlberg E. Clinical electrophysiology in myathenia gravis. J Neurol Neurosurg Psychiatry 1980;43:622-33.
6. Trontelj JV, Stȧlberg E. Jitter measurement by axonal micro-stimulation. Guidelines and technical notes. Electroencephal Clin Neurophysiol 1992;85:30-7.
7. Verma OK, Oger JJ. Seronegative generalized myasthenia gravis: low frequency of thymic pathology. Neurology 1992;42:586-9.
8. Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 1993;681:529-38.
9. Hoch W, Mcconville J, Helms S, et al. Auto-antibodies to the receptor tyrosine klnase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-8.
10. Liyanage Y, Hoch W, Beeson D, et al. The agrin/muscle specific kinase pathway: New target for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002;25:4-16.
11. Vincent A, Bowen J, Newsom-Davis J, et al. Seronegative generalized myasthenia gravis: clinical features, antibodies and their targets. Lancet Neurology 2003;2:99-106.
12. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11.
13. Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003;60:1978-80.
14. Buckley C, Newsom-Davis J, Willcox N, et al. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology 2001;57:1579-82.
15. Mygland A, Aarli JA, Matre R, et al. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994;57:843-6.
16. Skeie GO, Mygland A, Aarli JA, et al. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmumty 1995;29:99-104.
17. Jaretzki A, Barohn RJ, Ernstoff RM, et al. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Myasthenia gravis: recommendations for clinical research standard. Neurology 2000;55:16-23.
18. Beeson D, Jacobson L, Newsom-Davis J, et al. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 1996;47:1552-5.
19. McCorville J, Farugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2000;55:580-4.
20. Takamori M. Immunology of ryanodine receptor and FK506 in myasthenia gravis. Curr Top Peptide Protein Res 2003;5:187-99.
21. Sanders DB. Clinical impact of single-fiber electromyography. Muscle Nerve 2002;(Suppl 11):S15-20.
22. Iwasa K. Striational autoantibodies in myasthenia gravis mainly react with ryanodine receptor. Muscle Nerve 1997;20:753-6.
23. Iwasa K, Komai K, Takamori M. Spontaneous thymoma rat as a model for myesthenic weakness caused by anti-ryanodine receptor antibodies. Muscle Nerve 1998;21:1655-60.